Global Mobile Cardiac Telemetry Systems Market Size, Share, Growth Analysis, By Application(Lead-based and Patch-based), By End user(Hospitals, Cardiac centers) - Industry Forecast 2024-2031

Report ID: SQMIG35A2661 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 61 | Figures: 65

Global Mobile Cardiac Telemetry Systems Market Insights

Mobile Cardiac Telemetry Systems Market size was valued at USD 740 million in 2021 and is poised to grow from USD 830 million in 2022 to USD 2330 million by 2030, at a CAGR of 12.1% during the forecast period (2023-2030).

Mobile cardiac telemetry (MCAT) is an innovative and real-time cardiac monitoring technology that offers convenient and reliable monitoring of patients with cardiac diseases. These advanced devices automatically detect and transmit ECG rhythms without requiring patient participation to a distant diagnostic monitoring laboratory, enabling continuous monitoring for up to 30 days. The growing mortality rates attributed to the high prevalence of cardiovascular disorders in the population are significant drivers for the expansion of the mobile cardiac telemetry (MCAT) market. Unhealthy lifestyle choices, including physical inactivity, obesity, and smoking, contribute to increased cardiac disorder incidences. Moreover, MCAT devices are increasingly being used to rapidly detect arrhythmogenic risks in COVID-19 patients during outpatient care, fueling market growth. Technological advancements and increased investments in the development and manufacturing of these devices, coupled with their widespread utilization for remote patient monitoring to reduce hospitalizations, are further propelling the mobile cardiac telemetry (MCAT) market. Additionally, factors such as global population growth, heightened awareness about diseases and treatments, high mortality rates, increased healthcare expenditure, and rising disposable incomes are positively impacting the demand for MCAT solutions.

US Mobile Cardiac Telemetry Systems Market is poised to grow at a sustainable CAGR for the next forecast year.

Global Mobile Cardiac Telemetry Systems Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The competitive landscape of the mobile cardiac telemetry system market is characterized by the presence of several key players vying for market share. Established medical device companies and innovative startups are actively engaged in research and development to introduce advanced monitoring technologies. These companies are focusing on strategic collaborations, partnerships, and acquisitions to expand their product portfolios and global presence. Key players are also investing in marketing and promotional activities to increase product awareness among healthcare professionals and end-users. Factors such as product performance, reliability, pricing, and customer support play a crucial role in determining the competitive positioning of companies in the dynamic mobile cardiac telemetry system market. 'BioTelemetry, Inc.(US)', 'ScottCare(US)', 'Biotricity Inc. (US)', 'Welch Allyn(US)', 'Applied Cardiac Systems Inc. (US)', 'Medicomp Inc. (US)', 'Preventice Solutions(US)', 'Telerhythmics LLC(US)', 'Zoll Medical Corporation(US)', 'iRhythm Technologies, Inc. (US)'

The increasing adoption of minimally invasive surgical procedures in cardiac treatments is driving the demand for mobile cardiac telemetry systems. These systems offer real-time monitoring of patients' cardiac activities, enabling healthcare providers to assess patient conditions accurately during and after surgeries, leading to improved patient outcomes.

Mobile cardiac telemetry systems are witnessing a surge in demand due to the increasing popularity of remote patient monitoring. These systems enable real-time monitoring of a patient's cardiac health outside the hospital setting, allowing healthcare providers to track and analyze data remotely. This trend has been particularly significant during the COVID-19 pandemic, as it offers a safer option for patients and reduces the burden on healthcare facilities.

According to the region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America is currently the most dominant market for mobile cardiac telemetry systems. This is attributed to the presence of advanced healthcare infrastructure, a large number of hospitals and cardiac centers, and a high prevalence of cardiovascular diseases in the region. Additionally, favorable reimbursement policies and increased adoption of advanced medical technologies contribute to the market's dominance in North America.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Mobile Cardiac Telemetry Systems Market Size, Share, Growth Analysis, By Application(Lead-based and Patch-based), By End user(Hospitals, Cardiac centers) - Industry Forecast 2024-2031

Global Mobile Cardiac Telemetry Systems Market Insights

Global Mobile Cardiac Telemetry Systems Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Mobile Cardiac Telemetry Systems Market?

Who are the key vendors in the Global Mobile Cardiac Telemetry Systems Market?

What is the key driver of Global Mobile Cardiac Telemetry Systems Market?

What is the key market trend for Global Mobile Cardiac Telemetry Systems Market?

Which region accounted for the largest share in Global Mobile Cardiac Telemetry Systems Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300